Ovid Application Error
Therapeutic efficacy and safety of red blood cells treated with a chemical process (S-303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients.
Benjamin, Richard J. *; McCullough, Jeffrey *,+,++; Mintz, Paul D. *; Snyder, Edward *,++; Spotnitz, William D. *; Rizzo, Robert J.; Wages, David [S]; Lin, Jin-Sying [S]; Wood, Lindsey [S]; Corash, Laurence [S]; Conlan, Maureen G. [S]
45(11):1739-1749, November 2005.
(Format: HTML, PDF)